source
- Evolving Oral SERD Research Seeks to Redefine Treatment Strategies in Hormone Receptor+ Breast CancerBreast cancer experts discuss the nuances of ESR1 mutations and oral SERD use in hormone receptor–positive breast cancer.onclive · 2mo ago↗ source
- Immunotherapy Advances in Upfront SCAC Expose Need for Better Second-Line StrategiesAparna R. Parikh, MD, emphasizes the feasibility of immunotherapy trials in SCAC and the need for better treatment options in the second line and beyond.onclive · 2mo ago↗ source
- Hantavirus risk remains low, CDC says, citing its ‘playbook’ responseDespite rising concern about the hantavirus outbreak on a cruise ship, two CDC doctors say the risk to the public remains low.STAT